Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Laboratory Corp of America Holdings, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Laboratory Corp of America Holdings, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Laboratory Corp of America Holdings, Medical Equipment, Deal Details 17
Asset Purchase 17
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 17
Pharma Tech Solutions Acquires Genstrip From Shasta Technologies 19
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 20
Venture Financing 21
Orig3n Raises Funds through Initial Closing of Series B Financing 21
OmniSeq Plans to Raise Funds through Series B Financing 23
Sera Prognostics Raises USD40 Million in Series C Financing 24
Seventh Sense Biosystems Raises USD10 Million in Series C Financing 25
Ativa Medical Raises USD15 Million in Series B Financing 27
Vivify Health Raises Funds in Series B Venture Financing 29
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 30
Flatiron Health Raises US$130 Million In Series B Financing 32
Flatiron Health Raises US$8 Million In Series A Financing 34
Private Equity 36
Decision Diagnostics Plans to Raise USD4.7 Million in Financing 36
Partnerships 37
LabCorp Enters into Licensing Agreement with MDNA Life Sciences 37
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 38
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 39
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 41
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 42
LipoScience Enters Into Licensing Agreement With Cleveland Clinic 43
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer’s Diagnostic Technology 44
Covance Enters into Strategic Technology Agreement with GlaxoSmithKline 45
MC10 Enters into Partnership with LabCorp 46
OmniSeq Enters into Distribution Agreement with Laboratory Corp of America 47
Sera Prognostics Enters into Agreement with LabCorp 48
Interpace Diagnostics Extends Agreement with LabCorp 49
Sequenom enters into an Agreement with University of California 50
Sysmex Enters into Co-Development Agreement with LabCorp 51
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 52
Gamma-Dynacare Medical Labs Enters Into Agreement With OSR Medical 53
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 54
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 55
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 56
CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 57
CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 58
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 59
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 60
Equity Offering 61
MC10 Raises Funds through Private Placement of Shares 61
LipoScience Completes IPO For US$52 Million 62
Sequenom Completes Public Offering Of Common Stock For US$62 Million 64
Debt Offering 66
LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027 66
LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024 68
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 70
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 72
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 74
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 76
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 78
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 80
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 82
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 83
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 85
Asset Transactions 87
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 87
Marken Acquires European Kit Building Operation Facility From LabCorp 88
Acquisition 89
Eurofins Acquires Covance from LabCorp 89
LabCorp Acquires Sciformix 91
LabCorp Acquires Pathology Associates Medical Labs from Providence Health & Services and Catholic Health Initiatives 92
LabCorp Acquires ClearPath Diagnostics from Shore Capital Partners 94
LabCorp Acquires Sequenom 95
LabCorp Acquires Covance for USD6.1 Billion 97
LabCorp Acquires Bode Technology from SolutionPoint 99
LabCorp Acquires LipoScience for USD85.3 Million 100
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 102
Gamma-Dynacare Medical Labs Acquires Controlling Interest In Impact Genetics 103
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 104
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 105
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 107
Laboratory Corp of America Holdings – Key Competitors 108
Laboratory Corp of America Holdings – Key Employees 109
Laboratory Corp of America Holdings – Locations And Subsidiaries 110
Head Office 110
Other Locations & Subsidiaries 110
Recent Developments 115
Strategy And Business Planning 115
Jun 01, 2018: LabCorp and Unilabs Collaborate to Expand Global Reach of Precision Medicine Capabilities to Serve Patients, Physicians and Pharma 115
Jun 14, 2017: Covance Opens State-of-the-Art Laboratory for Companion Diagnostics 116
Apr 21, 2017: Covance to Expand Large-Molecule Development Capabilities in the UK 117
Financial Announcements 118
Jul 25, 2018: LabCorp Announces 2018 Second Quarter Results and Updates 2018 Guidance 118
Apr 25, 2018: LabCorp Announces Strong 2018 First Quarter Results and Updates 2018 Guidance 120
Feb 06, 2018: LabCorp Reports Net Revenue Of $2.70 Billion In The Fourth Quarter 2017 123
Oct 25, 2017: LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance 126
Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance 128
Apr 25, 2017: Laboratory Corporation of America Holdings Announces 2017 First Quarter Results and Updates 2017 Guidance 131
Feb 16, 2017: Laboratory Corporation of America Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance 133
Corporate Communications 136
Jul 12, 2018: Robert E. Mittelstaedt, Jr. to Retire from LabCorp Board of Directors and Current Board Member Adam H. Schechter to Assume Role of Lead Independent Director in 2019 136
Nov 13, 2017: LabCorp Receives 2017 Partnership Award from Be The Match 137
Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer 138
Jul 18, 2017: LabCorp’s William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center 139
Mar 29, 2017: LabCorp Promotes Executive Gary Huff to CEO of LabCorp Diagnostics, One of the Company’s Two Primary Business Segments 140
Legal and Regulatory 141
Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 141
Product News 142
Nov 16, 2017: Cority Enhances Clinical Testing Solution with LabCorp Interface 142
Sep 14, 2017: LabCorp Presents Nine Studies, Including Novel Research on Improving Genetic Counseling Quality, at the National Society of Genetic Counselors Annual Conference 143
Apr 28, 2017: LabCorp to Exclusively Offer the M3 Checklist, a Multi-Condition Mental Health Screening Tool 144
Other Significant Developments 146
May 25, 2018: LabCorp to Become a Preferred National Laboratory for Aetna 146
May 01, 2018: LabCorp Announces Collaboration with The Recovery Platform to Assist Physicians Treating Patients with Opioid Dependency 147
Sep 25, 2017: LabCorp Objects to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests; Calls for Delay in Implementation to Avoid Significant Harm to Medicare Beneficiaries 148
Jul 11, 2017: LabCorp and Novant Health Extend Laboratory Services Agreement 149
Jun 28, 2017: Walgreens and LabCorp Collaborate to Bring Patient Service Centers for Laboratory Testing to Select Walgreens Stores 150
Appendix 151
Methodology 151
About GlobalData 151
Contact Us 151
Disclaimer 151
Laboratory Corp of America Holdings, Medical Equipment, Key Facts, 2017 2
Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Laboratory Corp of America Holdings, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Laboratory Corp of America Holdings, Deals By Market, 2012 to YTD 2018 11
Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 17
Pharma Tech Solutions Acquires Genstrip From Shasta Technologies 19
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 20
Orig3n Raises Funds through Initial Closing of Series B Financing 21
OmniSeq Plans to Raise Funds through Series B Financing 23
Sera Prognostics Raises USD40 Million in Series C Financing 24
Seventh Sense Biosystems Raises USD10 Million in Series C Financing 25
Ativa Medical Raises USD15 Million in Series B Financing 27
Vivify Health Raises Funds in Series B Venture Financing 29
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 30
Flatiron Health Raises US$130 Million In Series B Financing 32
Flatiron Health Raises US$8 Million In Series A Financing 34
Decision Diagnostics Plans to Raise USD4.7 Million in Financing 36
LabCorp Enters into Licensing Agreement with MDNA Life Sciences 37
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 38
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 39
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 41
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 42
LipoScience Enters Into Licensing Agreement With Cleveland Clinic 43
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 44
Covance Enters into Strategic Technology Agreement with GlaxoSmithKline 45
MC10 Enters into Partnership with LabCorp 46
OmniSeq Enters into Distribution Agreement with Laboratory Corp of America 47
Sera Prognostics Enters into Agreement with LabCorp 48
Interpace Diagnostics Extends Agreement with LabCorp 49
Sequenom enters into an Agreement with University of California 50
Sysmex Enters into Co-Development Agreement with LabCorp 51
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 52
Gamma-Dynacare Medical Labs Enters Into Agreement With OSR Medical 53
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 54
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 55
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 56
CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 57
CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 58
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 59
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 60
MC10 Raises Funds through Private Placement of Shares 61
LipoScience Completes IPO For US$52 Million 62
Sequenom Completes Public Offering Of Common Stock For US$62 Million 64
LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027 66
LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024 68
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 70
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 72
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 74
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 76
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 78
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 80
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 82
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 83
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 85
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 87
Marken Acquires European Kit Building Operation Facility From LabCorp 88
Eurofins Acquires Covance from LabCorp 89
LabCorp Acquires Sciformix 91
LabCorp Acquires Pathology Associates Medical Labs from Providence Health & Services and Catholic Health Initiatives 92
LabCorp Acquires ClearPath Diagnostics from Shore Capital Partners 94
LabCorp Acquires Sequenom 95
LabCorp Acquires Covance for USD6.1 Billion 97
LabCorp Acquires Bode Technology from SolutionPoint 99
LabCorp Acquires LipoScience for USD85.3 Million 100
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 102
Gamma-Dynacare Medical Labs Acquires Controlling Interest In Impact Genetics 103
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 104
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 105
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 107
Laboratory Corp of America Holdings, Key Competitors 108
Laboratory Corp of America Holdings, Key Employees 109
Laboratory Corp of America Holdings, Other Locations 110
Laboratory Corp of America Holdings, Subsidiaries 111
List of Figures
Laboratory Corp of America Holdings, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Laboratory Corp of America Holdings, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Laboratory Corp of America Holdings, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Laboratory Corp of America Holdings, Medical Equipment, Deals by Market, 2012 to YTD 2018 11
